Progressive Multiple Sclerosis Completed Phase 2 Trials for Cysteine (DB00151)

Also known as: Progressive multiple sclerosis

IndicationStatusPhase
DBCOND0051688 (Progressive Multiple Sclerosis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02804594A Study of Oxidative Pathways in MS FatigueTreatment